New SARS-CoV-2 Variant Could Evade Antibodies
New SARS-CoV-2 Variant Could Evade Antibodies
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.
New SARS-CoV-2 Variant Could Evade Antibodies
New SARS-CoV-2 Variant Could Evade Antibodies

A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.

A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.

disease & medicine
Q&A: Natural History Museums’ Role in Pandemic Surveillance
Q&A: Natural History Museums’ Role in Pandemic Surveillance
Max Kozlov | Jan 21, 2021
Host vouchering, the practice of preserving species known to harbor infectious diseases, can be used to help determine a pathogen’s source, scientists say.
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Asher Jones | Jan 19, 2021
It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.
The Promise of Scientific Partnerships with People on the Spectrum
The Promise of Scientific Partnerships with People on the Spectrum
Laura Dattaro | Jan 18, 2021
Five collaborations involving autistic scientists and experts are advancing autism research, from lending support for theories of the condition to shoring up trials of new treatments.
Past SARS-CoV-2 Infection Mostly Protects Survivors
Past SARS-CoV-2 Infection Mostly Protects Survivors
Max Kozlov | Jan 14, 2021
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
High Risk of Bias in Early COVID-19 Studies: Meta-Analysis
Max Kozlov | Jan 14, 2021
Few peer-reviewed clinical papers on the pandemic contained original data, and many of those that did had poor experimental design.
Record Drop in US Cancer Death Rate
Record Drop in US Cancer Death Rate
Asher Jones | Jan 13, 2021
From 2017 to 2018, cancer deaths dropped by 2.4 percent, the largest single-year improvement recorded in 70 years of American Cancer Society annual cancer reports.
Q&A: Brown Fat Linked to Better Cardio and Metabolic Health
Q&A: Brown Fat Linked to Better Cardio and Metabolic Health
Amanda Heidt | Jan 12, 2021
Paul Cohen of the Rockefeller University describes his study of thousands of people, finding that the energy-burning tissue is tied to a lower risk of for several diseases, including type 2 diabetes, high blood pressure, and heart disease.
US Confirms World’s First SARS-CoV-2 Cases in Gorillas
US Confirms World’s First SARS-CoV-2 Cases in Gorillas
Max Kozlov | Jan 12, 2021
Zoo officials say the captive primates are recovering, but scientists worry the virus could spread quickly through dwindling wild populations.
Scientists Question Discovery of New Human Salivary Gland
Scientists Question Discovery of New Human Salivary Gland
Diana Kwon | Jan 12, 2021
A widely publicized paper has drawn scrutiny from physicians and anatomists about the authors’ claims regarding so-called tubarial glands.